查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587272

低溫運輸藥品市場：藥品、服務、溫度範圍、運輸 - 2025-2030 年全球預測

Cold-chain Pharma Market by Pharma Product (Biologics, Over-the-Counter Medicines, Prescribed Drugs), Services (Transportation, Warehousing & VAS), Temperature Range, Transportation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年低溫運輸藥品市場價值為78.9億美元，預計到2024年將達到88.5億美元，複合年成長率為12.65%，到2030年將達到181.8億美元。

低溫運輸藥品市場包括旨在將藥品維持在特定低溫下的物流、儲存和運輸系統。這種需求的根源在於維持溫度敏感藥物、疫苗和生技藥品的有效性和品質。重要的應用包括疫苗分發、生物製藥和臨床試驗材料，最終用戶範圍從醫院到實驗室再到零售藥局。由於全球對生物製藥和複雜生技藥品的需求不斷增加，以及對監管合規性和品質標準的日益關注，預計該市場將大幅成長。慢性病盛行率的上升和全球疫苗接種的推動，以及支援即時資料追蹤和預測分析的物聯網和人工智慧監控系統的技術進步，對這一成長做出了重大貢獻。然而，該行業面臨營運成本高、發展中地區基礎設施有限以及嚴格的監管環境等限制，為無縫擴張帶來了挑戰。

主要市場統計
基準年[2023] 78.9億美元
預測年份 [2024] 88.5億美元
預測年份 [2030] 181.8億美元
複合年成長率（%） 12.65%

在擴大新興市場的低溫運輸基礎設施以及開拓更永續和節能的技術以最大限度地減少碳足跡方面存在著巨大的機會。生物感測包裝和基於區塊鏈的可追溯性解決方案還有創新空間，可以提高供應鏈的透明度和安全性。市場相關人員還應該探索人工智慧和機器學習的進步，以進行預測性維護和路線最佳化，以降低物流成本。挑戰包括解決熟練勞動力的差距，適應快速的技術創新，同時確保品質和安全合規性。行業參與者應投資於培訓和發展計劃，並與高科技公司建立夥伴關係，以利用下一代技術。透過專注於穩健、適應性強的策略和永續實踐，公司可以利用新興機會並鞏固其市場定位。不斷探索環保材料和經濟高效、擴充性的解決方案可以確保在這個動態環境中的彈性和競爭力。

市場動態：揭示快速發展的低溫運輸藥品市場的關鍵市場洞察

供需的動態交互作用正在改變低溫運輸藥品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對溫度敏感的藥品和產品的儲存需求增加
    • 政府對藥品儲存和運輸的嚴格規定
    • 政府加大對研發活動的承諾
  • 市場限制因素
    • 冷庫建置及維護成本高
  • 市場機會
    • 疫苗開發、單株抗體和生技藥品的進展
    • 將物聯網和區塊鏈融入藥品低溫運輸
  • 市場挑戰
    • 醫藥低溫運輸物流運作複雜且缺乏熟練的專業人員

波特五力：駕馭低溫運輸醫藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解低溫運輸藥品市場的外部影響

外部宏觀環境因素對低溫運輸醫藥市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解低溫運輸藥品市場競爭狀況

對低溫運輸藥品市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV低溫運輸藥品市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估低溫運輸藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製低溫運輸藥品市場的成功之路

低溫運輸藥品市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對溫度敏感的藥品和產品的儲存需求增加
      • 政府對藥品儲存和運輸的嚴格規定
      • 加強政府對研發活動的承諾
    • 抑制因素
      • 冷藏保管區域的實施和維護成本較高
    • 機會
      • 疫苗開發、單株抗體和生技藥品的進展
      • 將物聯網和區塊鏈融入藥品低溫運輸
    • 任務
      • 醫藥低溫運輸物流運作複雜且缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章低溫運輸藥品市場藥品

  • 生物製藥
  • 非處方藥
  • 處方藥
  • 原料藥藥

第7章低溫運輸藥品市場：依服務分類

  • 運輸
  • 倉庫管理和加值服務

第8章以溫度範圍分類的低溫運輸藥品市場

  • 常溫
  • 冷藏
    • 冷凍的
    • 液相液態液態氮條件
    • 超級冷凍
    • 氣相液態氮

第9章 藥品低溫運輸市場運輸

  • 航路
  • 路
  • 航道

第10章美洲低溫運輸藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太低溫運輸藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲低溫運輸藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
  • AmerisourceBergen Corporation
  • Cavalier Logistics, Inc. by Mitsubishi Logistics
  • Continental AG
  • CWT Ltd.
  • DB Schenker
  • Deutsche Post AG
  • DHL International GmbH
  • FedEx Corporation
  • HCL Technologies Limited
  • Helapet ltd.
  • JWD InfoLogistics Public Co. Ltd.
  • Keppel Telecommunications & Transportation Ltd,
  • Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • Kuehne+Nagel Management AG
  • OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • SCG Logistics Management Co Ltd.
  • Tiong Nam Logistics Holdings Berhad
  • United Parcel Service, Inc.
  • VersaCold Logistics Services
  • WHA Group
  • Ych Group
  • Yusen Logistics Group
Product Code: MRR-7E6E70985BD9

The Cold-chain Pharma Market was valued at USD 7.89 billion in 2023, expected to reach USD 8.85 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 18.18 billion by 2030.

The cold-chain pharma market encompasses the logistics, storage, and transportation systems designed to maintain pharmaceutical products at designated low temperatures. Its necessity is rooted in preserving the efficacy and quality of temperature-sensitive drugs, vaccines, and biologics. Critical applications include vaccine distribution, biopharmaceuticals, and clinical trial materials, with end-users ranging from hospitals to research labs and retail pharmacies. The market is forecasted for substantial growth driven by increased global demand for biopharmaceuticals and complex biologics, coupled with heightened attention to regulatory compliance and quality standards. The rising prevalence of chronic diseases and the global push for immunization contribute significantly to this growth, alongside technological advancements in IoT and AI-powered monitoring systems aiding real-time data tracking and predictive analytics. However, the sector faces limitations such as high operational costs, limited infrastructure in developing regions, and stringent regulatory landscapes, which pose challenges to seamless expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 7.89 billion
Estimated Year [2024] USD 8.85 billion
Forecast Year [2030] USD 18.18 billion
CAGR (%) 12.65%

A substantial opportunity lies in expanding the cold chain infrastructure in emerging markets and developing more sustainable, energy-efficient technologies to minimize carbon footprints. There is an opening for innovation in biosensing packaging and blockchain-based traceability solutions, offering enhanced supply chain transparency and security. Market players should also explore advancements in AI and machine learning for predictive maintenance and route optimization to reduce logistics costs. Challenges include addressing the gap in skilled workforce and adapting to rapid technological changes while ensuring quality and safety compliance. Industry participants should invest in training and development programs and foster partnerships with tech firms to leverage next-gen technologies. By focusing on robust, adaptable strategies and sustainable practices, businesses can capitalize on burgeoning opportunities to solidify market positioning. Continuous research into eco-friendly materials and cost-effective, scalable solutions will ensure resilience and competitiveness in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold-chain Pharma Market

The Cold-chain Pharma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for storage of temperature-sensitive drugs and products
    • Stringent government regulations for pharmaceutical product storage and transportation
    • Increasing government initiatives for R&D activities
  • Market Restraints
    • High cost of execution for cold storage areas and maintenance
  • Market Opportunities
    • Advancement in vaccine development, monoclonal antibodies, and biologics
    • Integration of IoT and blockchain in pharma cold chain
  • Market Challenges
    • Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Cold-chain Pharma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold-chain Pharma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold-chain Pharma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold-chain Pharma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold-chain Pharma Market

A detailed market share analysis in the Cold-chain Pharma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold-chain Pharma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold-chain Pharma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold-chain Pharma Market

A strategic analysis of the Cold-chain Pharma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold-chain Pharma Market, highlighting leading vendors and their innovative profiles. These include AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S, AmerisourceBergen Corporation, Cavalier Logistics, Inc. by Mitsubishi Logistics, Continental AG, CWT Ltd., DB Schenker, Deutsche Post AG, DHL International GmbH, FedEx Corporation, HCL Technologies Limited, Helapet ltd., JWD InfoLogistics Public Co. Ltd., Keppel Telecommunications & Transportation Ltd,, Kerry Logistics Network Limited by SF Holding Co., Ltd., Kuehne + Nagel Management AG, OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited, SCG Logistics Management Co Ltd., Tiong Nam Logistics Holdings Berhad, United Parcel Service, Inc., VersaCold Logistics Services, WHA Group, Ych Group, and Yusen Logistics Group.

Market Segmentation & Coverage

This research report categorizes the Cold-chain Pharma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Pharma Product, market is studied across Biologics, Over-the-Counter Medicines, Prescribed Drugs, and Raw Materials & Bulk Pharmaceuticals.
  • Based on Services, market is studied across Transportation and Warehousing & VAS.
  • Based on Temperature Range, market is studied across Ambient and Refrigerated. The Refrigerated is further studied across Frozen, Liquid-Phase Liquid Nitrogen Conditions, Ultra-Frozen, and Vapour-Phase Liquid Nitrogen.
  • Based on Transportation, market is studied across Air-ways, Road, and Sea-Ways.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for storage of temperature-sensitive drugs and products
      • 5.1.1.2. Stringent government regulations for pharmaceutical product storage and transportation
      • 5.1.1.3. Increasing government initiatives for R&D activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of execution for cold storage areas and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in vaccine development, monoclonal antibodies, and biologics
      • 5.1.3.2. Integration of IoT and blockchain in pharma cold chain
    • 5.1.4. Challenges
      • 5.1.4.1. Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cold-chain Pharma Market, by Pharma Product

  • 6.1. Introduction
  • 6.2. Biologics
  • 6.3. Over-the-Counter Medicines
  • 6.4. Prescribed Drugs
  • 6.5. Raw Materials & Bulk Pharmaceuticals

7. Cold-chain Pharma Market, by Services

  • 7.1. Introduction
  • 7.2. Transportation
  • 7.3. Warehousing & VAS

8. Cold-chain Pharma Market, by Temperature Range

  • 8.1. Introduction
  • 8.2. Ambient
  • 8.3. Refrigerated
    • 8.3.1. Frozen
    • 8.3.2. Liquid-Phase Liquid Nitrogen Conditions
    • 8.3.3. Ultra-Frozen
    • 8.3.4. Vapour-Phase Liquid Nitrogen

9. Cold-chain Pharma Market, by Transportation

  • 9.1. Introduction
  • 9.2. Air-ways
  • 9.3. Road
  • 9.4. Sea-Ways

10. Americas Cold-chain Pharma Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cold-chain Pharma Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cold-chain Pharma Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
  • 2. AmerisourceBergen Corporation
  • 3. Cavalier Logistics, Inc. by Mitsubishi Logistics
  • 4. Continental AG
  • 5. CWT Ltd.
  • 6. DB Schenker
  • 7. Deutsche Post AG
  • 8. DHL International GmbH
  • 9. FedEx Corporation
  • 10. HCL Technologies Limited
  • 11. Helapet ltd.
  • 12. JWD InfoLogistics Public Co. Ltd.
  • 13. Keppel Telecommunications & Transportation Ltd,
  • 14. Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • 15. Kuehne + Nagel Management AG
  • 16. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • 17. SCG Logistics Management Co Ltd.
  • 18. Tiong Nam Logistics Holdings Berhad
  • 19. United Parcel Service, Inc.
  • 20. VersaCold Logistics Services
  • 21. WHA Group
  • 22. Ych Group
  • 23. Yusen Logistics Group

LIST OF FIGURES

  • FIGURE 1. COLD-CHAIN PHARMA MARKET RESEARCH PROCESS
  • FIGURE 2. COLD-CHAIN PHARMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLD-CHAIN PHARMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLD-CHAIN PHARMA MARKET DYNAMICS
  • TABLE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OVER-THE-COUNTER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRESCRIBED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RAW MATERIALS & BULK PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY WAREHOUSING & VAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AMBIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LIQUID-PHASE LIQUID NITROGEN CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-FROZEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VAPOUR-PHASE LIQUID NITROGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR-WAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROAD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SEA-WAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 236. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023